Printer Friendly

Printed from http://www.researchandmarkets.com/reports/2021920

Sleep Apnea - Pipeline Review, H1 2012

Description:
Sleep Apnea – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, 'Sleep Apnea - Pipeline Review, H1 2012', provides an overview of the Sleep Apnea therapeutic pipeline. This report provides information on the therapeutic development for Sleep Apnea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sleep Apnea. 'Sleep Apnea - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Sleep Apnea.
- A review of the Sleep Apnea products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Sleep Apnea pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Sleep Apnea.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Sleep Apnea pipeline depth and focus of Sleep Apnea therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Sleep Apnea Therapeutic Products under Development, Key Players in Sleep Apnea Therapeutics, Sleep Apnea Pipeline Overview, Sleep Apnea Pipeline, Sleep Apnea Pipeline Assessment
 
Contents:


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Sleep Apnea Overview
Therapeutics Development
An Overview of Pipeline Products for Sleep Apnea
Sleep Apnea Therapeutics under Development by Companies
Sleep Apnea Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Sleep Apnea Therapeutics – Products under Development by Companies
Sleep Apnea Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in Sleep Apnea Therapeutics Development
Merck & Co., Inc.
Cortex Pharmaceuticals, Inc.
BIOPROJET SCR
Sleep Apnea – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
CX1739 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MK-7288 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Xenical - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Buspirone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Caffeine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pitolisant - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Desogestrel - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Baclofen - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Branched-Chain Amino Acids - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Sleep Apnea Therapeutics – Drug Profile Updates
Sleep Apnea Therapeutics – Discontinued Products
Sleep Apnea – Product Development Milestones
Featured News & Press Releases
Apr 26, 2011: Cortex Receives US Patent For Lead AMPAKINE Molecule CX1739
Feb 02, 2011: Cortex’s Ampakine CX1739 Improves Respiratory Parameters In Obstructive Sleep Apnea Patients
Jan 25, 2011: Cephalon Announces Positive Topline Results From Phase IV Study Of NUVIGIL In Shift Work Disorder
Dec 27, 2010: Cephalon Receives Complete Response Letter For NUVIGIL
Oct 22, 2010: Cephalon Receives FDA Approval For Risk Evaluation And Mitigation Strategy Of NUVIGIL
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Sleep Apnea, H1 2012
Products under Development for Sleep Apnea – Comparative Analysis, H1 2012
Number of Products under Development by Companies, H1 2012
Number of Products under Investigation by Universities/Institutes, H1 2012
Comparative Analysis by Late Stage Development, H1 2012
Comparative Analysis by Mid Clinical Stage Development, H1 2012
Comparative Analysis by Early Clinical Stage Development, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Merck & Co., Inc., H1 2012
Cortex Pharmaceuticals, Inc., H1 2012
BIOPROJET SCR, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Molecule Type, H1 2012
Sleep Apnea Therapeutics – Drug Profile Updates
Sleep Apnea Therapeutics – Discontinued Products

List of Figures
Number of Products under Development for Sleep Apnea, H1 2012
Products under Development for Sleep Apnea – Comparative Analysis, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Late Stage Products, H1 2012
Mid Clinical Stage Products, H1 2012
Early Clinical Stage Products, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Route of Administration, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Molecule Type, H1 2012
Assessment by Stage and Molecule Type, H1 2012
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/2021920

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Sep 23th 2014
2:32:36 PM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Sleep Apnea - Pipeline Review, H1 2012

Web Address

http://www.researchandmarkets.com/reports/2021920

Office Code

OCGOOGLE

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User USD 500
Electronic (PDF) - Site License USD 1,000
Electronic (PDF) - Enterprisewide USD 1,500

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Sep 23th 2014
2:32:36 PM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)